Provided by Tiger Fintech (Singapore) Pte. Ltd.

Astria Therapeutics Inc

4.04
+0.06001.51%
Post-market: 4.040.00000.00%17:15 EDT
Volume:202.27K
Turnover:816.80K
Market Cap:227.99M
PE:-2.41
High:4.18
Open:3.97
Low:3.93
Close:3.98
Loading ...
Oct 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Oct 12, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 12, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 18, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 22, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 22, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Major Issues Report

8-K - Current report
Dec 22, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals